|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 世界胃肠病学组织(WGO-OMGE)临床指南——发展中国家幽门螺杆菌感染显示文摘我非常高兴向大家推荐这份发展中国家幽门螺杆菌(H.priori)临床指南。该指南的编译是由数位在该领域具有丰富临床经验的世界知名专家共同完成的。 | Hunt RH Xiao SD Megraud F Leon-Barua R Bazzoli F Van der Merwe S vaz Coelho LG Fock KM Fedail S Cohen H Malfertheiner P Vakil N Hamid S Goh KL Wong BC Krabshuis JH 杜颖 丛衍群 戴宁 | 2007 | 胃肠病学2007，12，1： | 85 |
| 2 | Multicenter,Phase Ⅱ study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma显示文摘 | Chan ATC Hsu MM Goh BC | 2005 | J Clin Oncol2005，23，15： | 1 |
| 3 | A warfarin dosing model in Asians that uses single-nucleotidepolymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9显示文摘 | THAM LS GOH BC NAFZIGER A | 2006 | Clin Pharmacol Ther2006，80，4： | 1 |
| 4 | Analyses of promoter hypermethylation for RUNX3 and other tumor suppressor genes in nasopharyneal carcinoma显示文摘 | Tan SH Ida H Goh BC | 2006 | Anticancer Research2006，26，6： | 1 |
| 5 | A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9 显示文摘 | Tham LS Goh BC Nafziger A | 2006 | Clin Pharmacol Ther2006，80，4： | 1 |
| 6 | Phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma 显示文摘 | Chan AT Hsu MM Goh BC | 2005 | J Clin Oncol2005，23，15： | 1 |
| 7 | A rapid and sensitive liquid chromatography/tandem mass spectrometry method for determination of docetaxel in human plasma显示文摘 | WANG LZ GOH BC GRIGG ME | 2003 | Rapid Commun Mass Spectrom2003，17，14： | 1 |
| 8 | Multicenter, phase Ⅱ study of cetuximab in combination with carboplatin in patients with recurrent or metastatic na-sopharyngeal carcinoma显示文摘 | Chan AT Hsu MM Goh BC | 2005 | J Clin Oncol2005，23，15： | 1 |
| 9 | CYP 2C19 genotype and the PPIs -- focus on rabeprazole 显示文摘 | Lim PW Goh KL Wong BC | 2005 | J Gastroenterol Hepatol2005，，： | 1 |
| 10 | An evaluation of the drug interaction potential of pazopanib,an oral vascular endothelial growth factor receptor tyro-sine kinase inhibitor,using a modified Cooperstown5+1cocktail in patients with advanced solid tumors显示文摘 | Goh BC Reddy NJ Dandamudi UB Laubscher KH Peckham T Hodge JP | 2010 | Clin Pharmacol Ther2010，88，5： | 1 |
| 11 | Analyses of promoter hypermethylation for RUNX3 and other tumor suppressor genes in nasopharyngeal carcinoma显示文摘 | Tan SH Ida H Goh BC | 2006 | Anticancer Res2006，26，6： | 1 |
| 12 | ABT-869,a promising multi-targeted tyrosine kinase inhibitor:from bench to bedside显示文摘 | Zhou J Goh BC Aibert DH | | 0，，01： | 1 |
| 13 | An innovative brilliant blue FCF method for fluorescent staining of fungi and bacteria显示文摘 | Chau HW Goh YK Si BC | 2011 | Biotech Histochem2011，86，4： | 1 |
| 14 | Multicenter,phase Ⅱ study of cetuximab in combination with carboplation in patients with recurent or metastatic nasopharyngeal carcinoma显示文摘 | Chan AT Hsu MM Goh BC | 2005 | J Clin Oncol2005，23，30： | 1 |
| 15 | Multicenter,phase Ⅱ study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma显示文摘 | Chan AT Hsu MM Goh BC | | 0，，15： | 1 |
| 16 | Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma 显示文摘 | Chan AT Hsu MM Goh BC | 2005 | J Clin Oncol2005，23，15： | 1 |
| 17 | A warfarin dosing model Asians thatuse ingle-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9 显示文摘 | Tham LS Goh BC Nafziger A | 2006 | Clin Phamacol Ther2006，80，4： | 1 |
| 18 | Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal car-cinoma显示文摘 | Chan ATC Hsu MM Goh BC | | 0，，15： | 1 |
| 19 | Phase Ⅱ trial of docetaxel in Asian patients with inoperable stage Ⅲ non-small cell lung cancer 显示文摘 | Goh BC Lehnert M Lim HL | 2000 | Acta Oncol2000，39，2： | 1 |
| 20 | A multicenter phaseⅡtrial of3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP,Triapine) and gemcitabine in advanced non-small-cell lungcancer with pharmacokinetic evaluation using peripheral blood mononuclear cells显示文摘 | Ma B Goh BC Tan EH | 2008 | Invest New Drugs2008，26，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员